A detailed history of General Pension Society Pzu Joint Stock CO transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, General Pension Society Pzu Joint Stock CO holds 163,107 shares of ITCI stock, worth $21.4 Million. This represents 4.18% of its overall portfolio holdings.

Number of Shares
163,107
Previous 163,107 -0.0%
Holding current value
$21.4 Million
Previous $11.9 Billion 14.15%
% of portfolio
4.18%
Previous 3.46%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Mar 10, 2025

SELL
$67.99 - $80.84 $3.48 Million - $4.14 Million
-51,167 Reduced 23.88%
163,107 $11.9 Billion
Q2 2024

Mar 10, 2025

BUY
$64.76 - $79.84 $13.9 Million - $17.1 Million
214,274 New
214,274 $14.7 Billion
Q1 2024

Mar 10, 2025

BUY
$64.37 - $75.65 $2.91 Million - $3.42 Million
45,167 Added 27.69%
208,274 $14.4 Billion
Q3 2023

Mar 10, 2025

SELL
$52.09 - $64.1 $1.09 Million - $1.35 Million
-21,000 Reduced 9.32%
204,274 $10.6 Billion
Q2 2023

Mar 10, 2025

SELL
$54.67 - $66.44 $1.2 Million - $1.46 Million
-21,946 Reduced 8.88%
225,274 $14.3 Billion
Q1 2023

Mar 10, 2025

BUY
$43.8 - $56.99 $3.68 Million - $4.79 Million
84,113 Added 51.57%
247,220 $13.4 Billion
Q4 2022

Mar 13, 2025

BUY
$44.07 - $54.45 $3.71 Million - $4.58 Million
84,113 Added 51.57%
247,220 $13.1 Billion
Q2 2022

Mar 13, 2025

SELL
$43.0 - $65.64 $584,456 - $892,178
-13,592 Reduced 5.21%
247,220 $14.1 Billion
Q1 2022

Mar 13, 2025

SELL
$38.74 - $62.09 $823,496 - $1.32 Million
-21,257 Reduced 7.54%
260,812 $16 Billion
Q4 2021

Mar 13, 2025

BUY
$35.2 - $53.42 $4.19 Million - $6.35 Million
118,962 Added 72.93%
282,069 $14.8 Billion
Q3 2021

Mar 13, 2025

BUY
$28.72 - $42.49 $7.67 Million - $11.3 Million
267,119 Added 1786.75%
282,069 $10.5 Billion
Q2 2021

Mar 13, 2025

SELL
$29.3 - $44.5 $4.34 Million - $6.59 Million
-148,157 Reduced 90.83%
14,950 $610 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.4B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track General Pension Society Pzu Joint Stock CO Portfolio

Follow General Pension Society Pzu Joint Stock CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Pension Society Pzu Joint Stock CO, based on Form 13F filings with the SEC.

News

Stay updated on General Pension Society Pzu Joint Stock CO with notifications on news.